Photodynamic therapy

Jump to: navigation, search

WikiDoc Resources for Photodynamic therapy


Most recent articles on Photodynamic therapy

Most cited articles on Photodynamic therapy

Review articles on Photodynamic therapy

Articles on Photodynamic therapy in N Eng J Med, Lancet, BMJ


Powerpoint slides on Photodynamic therapy

Images of Photodynamic therapy

Photos of Photodynamic therapy

Podcasts & MP3s on Photodynamic therapy

Videos on Photodynamic therapy

Evidence Based Medicine

Cochrane Collaboration on Photodynamic therapy

Bandolier on Photodynamic therapy

TRIP on Photodynamic therapy

Clinical Trials

Ongoing Trials on Photodynamic therapy at Clinical

Trial results on Photodynamic therapy

Clinical Trials on Photodynamic therapy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Photodynamic therapy

NICE Guidance on Photodynamic therapy


FDA on Photodynamic therapy

CDC on Photodynamic therapy


Books on Photodynamic therapy


Photodynamic therapy in the news

Be alerted to news on Photodynamic therapy

News trends on Photodynamic therapy


Blogs on Photodynamic therapy


Definitions of Photodynamic therapy

Patient Resources / Community

Patient resources on Photodynamic therapy

Discussion groups on Photodynamic therapy

Patient Handouts on Photodynamic therapy

Directions to Hospitals Treating Photodynamic therapy

Risk calculators and risk factors for Photodynamic therapy

Healthcare Provider Resources

Symptoms of Photodynamic therapy

Causes & Risk Factors for Photodynamic therapy

Diagnostic studies for Photodynamic therapy

Treatment of Photodynamic therapy

Continuing Medical Education (CME)

CME Programs on Photodynamic therapy


Photodynamic therapy en Espanol

Photodynamic therapy en Francais


Photodynamic therapy in the Marketplace

Patents on Photodynamic therapy

Experimental / Informatics

List of terms related to Photodynamic therapy

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.


Shown is close up of surgeons' hands in an operating room with a "beam of light" traveling along fiber optics for photodynamic therapy. Its source is a laser beam which is split at two different stages to create the proper "therapeutic wavelength". A patient would be given a photo sensitive drug (photofrin) containing cancer killing substances which are absorbed by cancer cells. During the surgery, the light beam is positioned at the tumor site, which then activates the drug that kills the cancer cells, thus photodynamic therapy (PDT).

Photodynamic therapy (PDT), matured as a feasible medical technology in the 1980s at several institutions throughout the world, is a ternary treatment for cancer involving three key components: a photosensitizer, light, and tissue oxygen. It is also being investigated for treatment of psoriasis and acne, and is an approved treatment for wet macular degeneration. The German physician Friedrich Meyer–Betz performed the first study with photodynamic therapy (PDT) with porphyrins in humans in 1913. Meyer–Betz tested the effects of haematoporphyrin-PDT on his own skin. Modern day versions of it were tested at the Mayo Clinic and Roswell Park Cancer Center, but did not really become widespread until Thomas Dougherty initiated clinical trials and formed the International Photodynamic Association, in 1986.

Mechanism of Action

A photosensitizer is a chemical compound that can be excited by light of a specific wavelength. This excitation uses visible or near-infrared light. In photodynamic therapy, either a photosensitizer or the metabolic precursor of one is administered to the patient. The tissue to be treated is exposed to light suitable for exciting the photosensitizer. Usually, the photosensitizer is excited from a ground singlet state to an excited singlet state. It then undergoes intersystem crossing to a longer-lived excited triplet state. One of the few chemical species present in tissue with a ground triplet state is molecular oxygen. When the photosensitizer and an oxygen molecule are in proximity, an energy transfer can take place that allows the photosensitizer to relax to its ground singlet state, and create an excited singlet state oxygen molecule. Singlet oxygen is a very aggressive chemical species and will very rapidly react with any nearby biomolecules. (The specific targets depend heavily on the photosensitizer chosen.) Ultimately, these destructive reactions will result in cell killing through apoptosis or necrosis.

As an example, consider PDT as a treatment for basal cell carcinoma (BCC). BCC is the most common form of skin cancer in humans. Conventional treatment of BCC involves surgical excision, cryogenic treatment with liquid nitrogen, or localized chemotherapy with 5-fluorouracil or other agents.

A PDT treatment would involve the following steps.

  • A photosensitizer precursor (aminolevulinic acid (ALA) or methyl aminolevulinate) is applied.
  • A waiting period of a few hours is allowed to elapse, during which time
    • ALA will be taken up by cells, and
    • ALA will be converted by the cells to protoporphyrin IX, a photosensitizer (see Porphyrin).
  • The physician shines a bright red light (from an array of light-emitting diodes or a diode laser) on the area to be treated. The light exposure lasts a few minutes to a few tens of minutes.
    • Protoporphyrin IX absorbs light, exciting it to an excited singlet state;
    • Intersystem crossing occurs, resulting in excited triplet protoporphyrin IX;
    • Energy is transferred from triplet protoporphyrin IX to triplet oxygen, resulting in singlet (ground state) protoporphyrin IX and excited singlet oxygen;
    • Singlet oxygen reacts with biomolecules, fatally damaging some cells in the treatment area.
  • Within a few days, the exposed skin and carcinoma will scab over and flake away.
  • In a few weeks, the treated area has healed, leaving healthy skin behind. For extensive malignancies, repeat treatments may be required. It is also common to experience pain from the area treated.
  • After the treatment the patient will need to avoid excessive exposure to sunlight for a period of time.

This mechanism is identical to the mechanism of the disease Porphyria cutanea tarda, which causes blistering in response to sun exposure due to a genetic defect in the same metabolic pathway.

Specificity of treatment is achieved in three ways. First, light is delivered only to tissues that a physician wishes to treat. In the absence of light, there is no activation of the photosensitizer and no cell killing. Second, photosensitizers may be administered in ways that restrict their mobility. In our example, ALA was only applied to the area to be treated. Finally, photosensitizers may be chosen which are selectively absorbed at a greater rate by targeted cells. ALA is taken up much more rapidly by metabolically active cells. Since malignant cells tend to be growing and dividing much more quickly than healthy cells, the ALA targets the unhealthy cells.

Treatment of internal organs may be achieved through the use of endoscopes and fiber optic catheters to deliver light, and intravenously-administered photosensitizers. A great deal of research and clinical study is now underway to determine optimal combinations of photosensitizers, light sources, and treatment parameters for a wide variety of different cancers.

A major disadvantage of PDT is that the light needed to activate most photosensitizers can not penetrate through more than one third of an inch (1 cm) of tissue. Thus the application of PDT is limited to the treatment of tumours on or under the skin, or on the lining of some internal organs. Moreover it is less effective in treatment of large tumours and metastasis because of the same reason.

See also

Post surgical removal of large tumors PDT can be useful in removing traces of malignant tissue.

External links


Cost Effectiveness of Photodynamic therapy

| group5 = Clinical Trials Involving Photodynamic therapy | list5 = Ongoing Trials on Photodynamic therapy at Clinical Trials.govTrial results on Photodynamic therapyClinical Trials on Photodynamic therapy at Google

| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Photodynamic therapy | list6 = US National Guidelines Clearinghouse on Photodynamic therapyNICE Guidance on Photodynamic therapyNHS PRODIGY GuidanceFDA on Photodynamic therapyCDC on Photodynamic therapy

| group7 = Textbook Information on Photodynamic therapy | list7 = Books and Textbook Information on Photodynamic therapy

| group8 = Pharmacology Resources on Photodynamic therapy | list8 = AND (Dose)}} Dosing of Photodynamic therapyAND (drug interactions)}} Drug interactions with Photodynamic therapyAND (side effects)}} Side effects of Photodynamic therapyAND (Allergy)}} Allergic reactions to Photodynamic therapyAND (overdose)}} Overdose information on Photodynamic therapyAND (carcinogenicity)}} Carcinogenicity information on Photodynamic therapyAND (pregnancy)}} Photodynamic therapy in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Photodynamic therapy

| group9 = Genetics, Pharmacogenomics, and Proteinomics of Photodynamic therapy | list9 = AND (pharmacogenomics)}} Genetics of Photodynamic therapyAND (pharmacogenomics)}} Pharmacogenomics of Photodynamic therapyAND (proteomics)}} Proteomics of Photodynamic therapy

| group10 = Newstories on Photodynamic therapy | list10 = Photodynamic therapy in the newsBe alerted to news on Photodynamic therapyNews trends on Photodynamic therapy

| group11 = Commentary on Photodynamic therapy | list11 = Blogs on Photodynamic therapy

| group12 = Patient Resources on Photodynamic therapy | list12 = Patient resources on Photodynamic therapyDiscussion groups on Photodynamic therapyPatient Handouts on Photodynamic therapyDirections to Hospitals Treating Photodynamic therapyRisk calculators and risk factors for Photodynamic therapy

| group13 = Healthcare Provider Resources on Photodynamic therapy | list13 = Symptoms of Photodynamic therapyCauses & Risk Factors for Photodynamic therapyDiagnostic studies for Photodynamic therapyTreatment of Photodynamic therapy

| group14 = Continuing Medical Education (CME) Programs on Photodynamic therapy | list14 = CME Programs on Photodynamic therapy

| group15 = International Resources on Photodynamic therapy | list15 = Photodynamic therapy en EspanolPhotodynamic therapy en Francais

| group16 = Business Resources on Photodynamic therapy | list16 = Photodynamic therapy in the MarketplacePatents on Photodynamic therapy

| group17 = Informatics Resources on Photodynamic therapy | list17 = List of terms related to Photodynamic therapy

}} de:Photodynamische Therapie sv:Fotodynamisk terapi